Vera Therapeutics

10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
What about the company Vertex didn’t buy?
Stat
Fri, 04/12/24 - 11:05 am
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
Vera Therapeutics
IgA nephropathy
Vera Therapeutics’ stock could rise by 70%, according to Wall Street analysts
Motley Fool
Mon, 12/18/23 - 11:35 am
Vera Therapeutics
IgA nephropathy
ERA 2023 – longer is stronger for Vera
EP Vantage
Tue, 06/20/23 - 09:59 am
ERA
Vera Therapeutics
IgAN
atacicept
immunoglobulin A nephropathy
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Novartis
Chinook Therapeutics
April inhibition
M&A
Vera Therapeutics
Otsuka
RemeGen
Alpine Immune Sciences
Akso Biopharmaceutical
Aurinia Pharmaceuticals
Vera finally notches a win for Merck KGaA castoff in autoimmune kidney disease
Fierce Biotech
Tue, 01/3/23 - 10:21 pm
Vera Therapeutics
Merck KGaA
autoimmune kidney disease
atacicept
Catalysts ahead for the smaller players
EP Vantage
Wed, 12/21/22 - 11:19 am
89Bio
Altimmune
AnaptysBio
BioXcel Therapeutics
Calliditas Therapeutics
Eli Lilly
Esperion Therapeutics
Geron
Nektar Therapeutics
Oramed Pharmaceuticals
Pliant Therapeutics
Replimune
Selecta Biosciences
Swedish Orphan Biovitrum
Vera Therapeutics
Viking Therapeutics
Seres, Vera Notch Weekend Wins in C.Diff, Lupus Trials
BioSpace
Mon, 05/23/22 - 10:22 am
Seres Therapeutics
clinical trials
SER-109
C. difficile
Vera Therapeutics
lupus
atacicept
Startup targets orphan kidney disease with former Merck drug
MedCity News
Tue, 01/26/21 - 11:10 am
Vera Therapeutics
Merck
funding
kidney disease
immunoglobin A nephropathy
atacicept
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Fierce Biotech
Tue, 01/19/21 - 10:38 am
Vera Therapeutics
Merck KGaA
clinical trials
kidney disease
atacicept
Gilead Sciences